TEST:

Lung Cancer 8-Gene Kit

"Genetron Holdings Limited...announced that it has signed a collaboration agreement with HUTCHMED (China) Limited...for the joint development of a companion diagnostic (CDx) test for ORPATHYS® (savolitinib) in China. Under the agreement, the partners plan to jointly validate and register Genetron Health’s approved NGS-based 8-gene Lung Cancer Assay (Tissue) as CDx for ORPATHYS®."

"Genetron Holdings Limited...announced that it has signed a collaboration agreement with HUTCHMED (China) Limited...for the joint development of a companion diagnostic (CDx) test for ORPATHYS® (savolitinib) in China...Under the agreement, the partners plan to jointly validate and register Genetron Health’s approved NGS-based 8-gene Lung Cancer Assay (Tissue) as CDx for ORPATHYS®."

"Genetron Health...announced the launch of the 'Lung Loves New Life' genetic testing campaign, in collaboration with the China Primary Health Care Foundation. As the sole corporate donor, Genetron Health will provide free genetic testing services (using its 8-gene lung cancer assay) for 10,000 Chinese lung cancer patients. These tests will become an important reference for patients to customize their follow-up treatment regimens."